All Relations between cannabis and Epilepsy

Publication Sentence Publish Date Extraction Date Species
Yasaman Javadzadeh, Alexandra Santos, Mark S Aquilino, Shanthini Mylvaganam, Karolina Urban, Peter L Carle. Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ Cells. vol 13. issue 6. 2024-03-27. PMID:38534310. cannabidiol exerts anticonvulsant effects alone and in combination with Δ cannabinoids have shown potential in drug-resistant epilepsy treatment; however, we lack knowledge on which cannabinoid(s) to use, dosing, and their pharmacological targets. 2024-03-27 2024-03-29 Not clear
Correction to "Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access program". Epilepsia. 2024-03-19. PMID:38502122. correction to "long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: four-year results from the expanded access program". 2024-03-19 2024-03-21 Not clear
Giovanni Battista Dell'isola, Alberto Verrotti, Miriam Sciaccaluga, Gianluca Dini, Pietro Ferrara, Lucilla Parnetti, Cinzia Cost. Cannabidiol: metabolism and clinical efficacy in epileptic patients. Expert opinion on drug metabolism & toxicology. 2024-03-11. PMID:38465404. the landscape of epilepsy treatment has undergone a significant transformation with the emergence of cannabidiol as a potential therapeutic agent. 2024-03-11 2024-03-14 Not clear
Correction to "Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access program". Epilepsia. 2024-02-29. PMID:38420790. correction to "long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: four-year results from the expanded access program". 2024-02-29 2024-03-02 Not clear
Ayushe A Sharma, Jerzy P Szaflarsk. The longitudinal effects of cannabidiol on brain temperature in patients with treatment-resistant epilepsy. Epilepsy & behavior : E&B. vol 151. 2024-01-10. PMID:38199054. the longitudinal effects of cannabidiol on brain temperature in patients with treatment-resistant epilepsy. 2024-01-10 2024-01-13 human
Christopher Martínez-Aguirre, Luis Alfredo Márquez, Cindy Lizbeth Santiago-Castañeda, Francia Carmona-Cruz, Maria de Los Angeles Nuñez-Lumbreras, Vladimir A Martínez-Rojas, Mario Alonso-Vanegas, Gustavo Aguado-Carrillo, Norma L Gómez-Víquez, Emilio J Galván, Manola Cuéllar-Herrera, Luisa Roch. Cannabidiol Modifies the Glutamate Over-Release in Brain Tissue of Patients and Rats with Epilepsy: A Pilot Study. Biomedicines. vol 11. issue 12. 2023-12-23. PMID:38137458. cannabidiol modifies the glutamate over-release in brain tissue of patients and rats with epilepsy: a pilot study. 2023-12-23 2023-12-25 rat
Long Chen, Yuan Sun, Jinran Li, Sai Liu, Hancheng Ding, Guangji Wang, Xinuo L. Assessing Cannabidiol as a Therapeutic Agent for Preventing and Alleviating Alzheimer's Disease Neurodegeneration. Cells. vol 12. issue 23. 2023-12-09. PMID:38067101. cannabidiol (cbd), derived from cannabis, is noted for its neuroprotective and anti-inflammatory properties, having shown efficacy in neuropathic pain management for epilepsy. 2023-12-09 2023-12-17 Not clear
Anumita Samanta, Adrian Aleman-Zapata, Kopal Agarwal, Pelin Özsezer, Alejandra Alonso, Jacqueline van der Meij, Abdelrahman Rayan, Irene Navarro-Lobato, Lisa Genze. CBD lengthens sleep but shortens ripples and leads to intact simple but worse cumulative memory. iScience. vol 26. issue 11. 2023-12-01. PMID:38026151. cannabidiol (cbd) is on the rise as over-the-counter medication to treat sleep disturbances, anxiety, pain, and epilepsy due to its action on the excitatory/inhibitory balance in the brain. 2023-12-01 2023-12-10 rat
Michal Tzadok, Rotem Gur-Pollack, Hadar Florh, Yael Michaeli, Tal Gilboa, Mirit Lezinger, Eli Heyman, Veronika Chernuha, Irina Gudis, Andreea Nissenkorn, Tally Lerman-Sagie, Bruria Ben Zeev, Shimrit Uliel-Sibon. Real-Life Experience With Purified Cannabidiol Treatment for Refractory Epilepsy: A Multicenter Retrospective Study. Pediatric neurology. vol 150. 2023-11-23. PMID:37995414. real-life experience with purified cannabidiol treatment for refractory epilepsy: a multicenter retrospective study. 2023-11-23 2023-11-29 Not clear
Lucy Roberts-West, Sallie Baxendal. The impact of recreational cannabis use on neuropsychological function in epilepsy. Epilepsy & behavior reports. vol 24. 2023-11-13. PMID:37954009. the impact of recreational cannabis use on neuropsychological function in epilepsy. 2023-11-13 2023-11-20 Not clear
Lucy Roberts-West, Sallie Baxendal. The impact of recreational cannabis use on neuropsychological function in epilepsy. Epilepsy & behavior reports. vol 24. 2023-11-13. PMID:37954009. cannabis use is associated with neuropsychological impairments in the general population, but little is known about the impact on cognitive function in people with epilepsy who are already at increased risk of difficulties due to the essential comorbidities of the disease. 2023-11-13 2023-11-20 Not clear
Lucy Roberts-West, Sallie Baxendal. The impact of recreational cannabis use on neuropsychological function in epilepsy. Epilepsy & behavior reports. vol 24. 2023-11-13. PMID:37954009. we compared the performance of 42 people with epilepsy (pwe) who reported regular cannabis use with 254 age matched, non-cannabis-using pwe. 2023-11-13 2023-11-20 Not clear
Lucy Roberts-West, Sallie Baxendal. The impact of recreational cannabis use on neuropsychological function in epilepsy. Epilepsy & behavior reports. vol 24. 2023-11-13. PMID:37954009. cannabis use was not associated with epilepsy type. 2023-11-13 2023-11-20 Not clear
Lucy Roberts-West, Sallie Baxendal. The impact of recreational cannabis use on neuropsychological function in epilepsy. Epilepsy & behavior reports. vol 24. 2023-11-13. PMID:37954009. our data indicates that recreational cannabis use in people with epilepsy amplifies deficits in new learning and enhances susceptibility to distraction in the retention of newly learnt material. 2023-11-13 2023-11-20 Not clear
Shengyi Liu, Zihua He, Jinmei L. Long-term efficacy and adverse effects of cannabidiol in adjuvant treatment of drug-resistant epilepsy: a systematic review and meta-analysis. Therapeutic advances in neurological disorders. vol 16. 2023-11-02. PMID:37915501. long-term efficacy and adverse effects of cannabidiol in adjuvant treatment of drug-resistant epilepsy: a systematic review and meta-analysis. 2023-11-02 2023-11-08 Not clear
Aaron J Rozental, Brooke G Weisbeck, Isabella Corsato Alvarenga, Daniel L Gustafson, Breonna R Kusick, Sangeeta Rao, Lisa R Bartner, Stephanie McGrat. The efficacy and safety of cannabidiol as adjunct treatment for drug-resistant idiopathic epilepsy in 51 dogs: A double-blinded crossover study. Journal of veterinary internal medicine. 2023-10-27. PMID:37889215. the efficacy and safety of cannabidiol as adjunct treatment for drug-resistant idiopathic epilepsy in 51 dogs: a double-blinded crossover study. 2023-10-27 2023-11-08 Not clear
Orrin Devinsky, Nicholas A Jones, Mark O Cunningham, B Ashan P Jayaskera, Sasha Devore, Benjamin J Whalle. Cannabinoid treatments in epilepsy and seizure disorders. Physiological reviews. 2023-10-26. PMID:37882730. in the last few decades, preclinical animal studies and clinical investigations have established the role of cannabidiol (cbd) in treating epilepsy and seizures and support potential therapeutic benefits for cannabinoids in other neurological and psychiatric disorders. 2023-10-26 2023-11-08 Not clear
Jeremy Danie. Cannabidiol for the Treatment of Pediatric Epilepsy. Pediatric annals. vol 52. issue 10. 2023-10-11. PMID:37820705. cannabidiol for the treatment of pediatric epilepsy. 2023-10-11 2023-10-15 Not clear
Jeremy Danie. Cannabidiol for the Treatment of Pediatric Epilepsy. Pediatric annals. vol 52. issue 10. 2023-10-11. PMID:37820705. this article seeks to provide a pathophysiological basis for cannabidiol in epilepsy, discuss commercially available products and nonpharmaceutical marijuana, and review recent evidence in pediatric epilepsy. 2023-10-11 2023-10-15 Not clear
M Perriguey, M El Succar, A Clément, S Lagarde, O Ribes, X Dode, S Rheims, F Bartolome. High-purified cannabidiol efficacy and safety in a cohort of adult patients with various types of drug-resistant epilepsies. Revue neurologique. 2023-10-08. PMID:37806886. high-purified cannabidiol efficacy and safety in a cohort of adult patients with various types of drug-resistant epilepsies. 2023-10-08 2023-10-15 Not clear